Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001701478-25-000040
Filing Date
2025-08-11
Accepted
2025-08-11 16:01:34
Documents
76
Period of Report
2025-06-30

Document Format Files

Seq Description Document Type Size
1 10-Q aztr-20250630.htm   iXBRL 10-Q 1064614
2 EX-31.1 aztr-20250630xexx311.htm EX-31.1 9970
3 EX-31.2 aztr-20250630xexx312.htm EX-31.2 10389
4 EX-32.1 aztr-20250630xexx321.htm EX-32.1 8430
10 aztr-20250630_g1.jpg GRAPHIC 6997
11 aztr-20250630_g2.jpg GRAPHIC 90435
  Complete submission text file 0001701478-25-000040.txt   6914036

Data Files

Seq Description Document Type Size
5 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT aztr-20250630.xsd EX-101.SCH 53039
6 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT aztr-20250630_cal.xml EX-101.CAL 62267
7 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT aztr-20250630_def.xml EX-101.DEF 247976
8 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT aztr-20250630_lab.xml EX-101.LAB 664875
9 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT aztr-20250630_pre.xml EX-101.PRE 474006
79 EXTRACTED XBRL INSTANCE DOCUMENT aztr-20250630_htm.xml XML 787260
Mailing Address 21 BUSINESS PARK DRIVE, SUITE 6 BRANFORD CT 06405
Business Address 21 BUSINESS PARK DRIVE, SUITE 6 BRANFORD CT 06405 (203) 489-0183
Azitra, Inc. (Filer) CIK: 0001701478 (see all company filings)

EIN.: 464478536 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-41705 | Film No.: 251201900
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)